1-2 of 2
Michael R. Green
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Inhibition of MALT1 and BCL2 Induces Synergistic Antitumor Activity in Models of B-Cell Lymphoma

Joshua P. Plotnik, Adam E. Richardson, Haopeng Yang, Estela Rojas, Velitchka Bontcheva, Colleen Dowell, Sydney Parsons, Ashley Wilson, Vida Ravanmehr, Christine Will, Paul Jung, Haizhong Zhu, Sarathy Karunan Partha, Sanjay C. Panchal, Raghuveer Singh Mali, Frederick J. Kohlhapp, Ryan A. McClure, Cyril Y. Ramathal, Mariam D. George, Manisha Jhala, Nathaniel L. Elsen, Wei Qiu, Russell A. Judge, Chin Pan, Anthony Mastracchio, Jared Henderson, Jonathan A. Meulbroek, Michael R. Green, William N. Pappano
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2024) 23 (7): 949–960.
https://doi.org/10.1158/1535-7163.MCT-23-0518
Published: 02 July 2024
View article titled, Inhibition of MALT1 and BCL2 Induces Synergistic Antitumor Activity in Models of B-Cell Lymphoma
Open the PDF for Inhibition of MALT1 and BCL2 Induces Synergistic Antitumor Activity in Models of B-Cell Lymphoma in another window
Includes: Supplementary data
Journal Articles

Efficacy of IGFBP7 for treatment of metastatic melanoma and other cancers in mouse models and human cell lines

Narendra Wajapeyee, Varun Kapoor, Meera Mahalingam, Michael R. Green
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2009) 8 (11): 3009–3014.
https://doi.org/10.1158/1535-7163.MCT-09-0470
Published: 10 November 2009
View article titled, Efficacy of IGFBP7 for treatment of metastatic melanoma and other cancers in mouse models and human cell lines
Open the PDF for Efficacy of IGFBP7 for treatment of metastatic melanoma and other cancers in mouse models and human cell lines in another window
Includes: Supplementary data